Clinical trial
A Real-world, Multi-centre, Prospective, Non-interventional, Single-arm Study Investigating Glycaemic Control, Treatment Satisfaction and Adherence Associated With the Switch From Daily Basal Insulin to Insulin Icodec in People Living With Type 2 Diabetes in China
NCT07658417 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-world, Multi-centre, Prospective, Non-interventional, Single-arm Study Investigating Glycaemic Control, Treatment Satisfaction and Adherence Associated With the Switch From Daily Basal Insulin to Insulin Icodec in People Living With Type 2 Diabetes in China
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 2, 2026
- Completion date
- December 1, 2027
- Enrollment
- 216 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.